Trials / Active Not Recruiting
Active Not RecruitingNCT06579287
A Study of SHJ002 Sterile Ophthalmic Solution for Myopia Control
A Phase II Study to Determine the Safety and Efficacy of SHJ002 Sterile Ophthalmic Solution on Myopia Control in Subjects Aged 3-12 Years.
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 140 (actual)
- Sponsor
- Sunhawk Vision Biotech, Inc. · Industry
- Sex
- All
- Age
- 3 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to explore the safety and efficacy of SHJ002 Sterile Ophthalmic Solution relative to atropine in myopia control SHJ002 is an antisense oligonucleotide to neutralize a specific microRNA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHJ002 | Topical ophthalmic |
| DRUG | Atropine | Topical ophthalmic |
Timeline
- Start date
- 2025-01-22
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2024-08-30
- Last updated
- 2026-01-23
Locations
9 sites across 2 countries: United States, Taiwan
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06579287. Inclusion in this directory is not an endorsement.